Clinical trial
Magnetic Resonance Imaging to Measure Treatment Effects of Doxycycline and Rifampicin in Alzheimer's Disease
NCT00692588 is registered in ClinicalTrials.gov with St. Joseph's Healthcare Hamilton as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Magnetic Resonance Imaging to Measure Treatment Effects of Doxycycline and Rifampicin in Alzheimer's Disease
- Lead sponsor
- St. Joseph's Healthcare Hamilton
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- June 30, 2010
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease